Discovering the
future of medicine

The FDA announced the licensing of the rotavirus vaccine developed collaboratively by Wistar, Children’s Hospital of Philadelphia, and Merck & Co., Inc. in the 1980s. The vaccine is sold as ROTATEQ® and is part of the recommended immunization schedule for infants 6 weeks to 32 weeks of age.